Enhanced Production of 3-Phenyllactic Acid From Novel Non-Axenic Coculture: Adaptive Evolution and Statistical Fermentation Studies

dc.contributor.author Meruvu, Haritha
dc.date.accessioned 2023-11-11T08:56:20Z
dc.date.available 2023-11-11T08:56:20Z
dc.date.issued 2024
dc.description Meruvu, Haritha/0000-0002-4494-5511 en_US
dc.description.abstract This research pivots around screening of idoneous lactic acid bacteria (LAB) from cow milk and subjecting them to adaptive evolution experiments to aid superior growth/robustness necessary for 3-phenyllactic acid (3-PLA) production. Conventional and statistical fermentation studies were conducted at batch scale using a non-axenic coculture of three novel LAB strains: Lactiplantibacillus plantarum str. nov. plantharim, Lactobacillus delbrueckki str. nov. delharim, and Pediococcus pentasaceous str. nov. pentharim. Statistically optimized fermentation using Box Behnken technique resulted in 1225 mg/L 3-PLA production using the growth medium: cheese whey-MRS medium mixture (5:2 ratio), phenylalanine (2.69% w/v), and glucose (9.6% w/v). Statistical optimization of fermentation parameters resulted in a substantial increase (17 times higher) compared to the non-optimized fermentation conditions (72 mg/L). Monad growth kinetics of the cow milk whey (CMW) coculture were calculated and estimated as: mu(max)=0.336 h(-1), K-s=11.64 mg/mL, Y-x/s=0.835 mg/g, Y-P/S=1.66 mg/g, Y-X/P=0.112 mg/mg. The purified 3-PLA (1.93 mg/mL) showed antimicrobial activity with pathogenic bacteria like Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus, with a minimum inhibitory concentration of 12 mg/mL. en_US
dc.description.sponsorship European Union [801509]; Brain Circulation Scheme [TUBITAK-2236, 121C360] en_US
dc.description.sponsorship This article is part of project work supported by the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No. 801509 and TUBITAK-2236 Co-Funded Brain Circulation Scheme 2: Project number 121C360, Dr. Haritha Meruvu (grant recipient) profoundly expresses her gratitude for the same. en_US
dc.identifier.doi 10.1007/s13399-023-04895-2
dc.identifier.issn 2190-6815
dc.identifier.issn 2190-6823
dc.identifier.scopus 2-s2.0-85172786727
dc.identifier.uri https://doi.org/10.1007/s13399-023-04895-2
dc.language.iso en en_US
dc.publisher Springer Heidelberg en_US
dc.relation.ispartof Biomass Conversion and Biorefinery en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Cheese Whey en_US
dc.subject Phenyllactic Acid en_US
dc.subject Lactic Acid Bacteria en_US
dc.subject Fermentation en_US
dc.subject Coculture en_US
dc.subject Antimicrobial Activity en_US
dc.title Enhanced Production of 3-Phenyllactic Acid From Novel Non-Axenic Coculture: Adaptive Evolution and Statistical Fermentation Studies en_US
dc.type Article en_US
dspace.entity.type Publication
gdc.author.id MERUVU, HARITHA / 0000-0002-4494-5511 en_US
gdc.author.id Meruvu, Haritha/0000-0002-4494-5511
gdc.author.id Meruvu, Haritha/0000-0002-4494-5511
gdc.author.institutional Meruvu, Haritha
gdc.author.wosid Meruvu, Haritha/V-3222-2017
gdc.bip.impulseclass C5
gdc.bip.influenceclass C5
gdc.bip.popularityclass C5
gdc.coar.access metadata only access
gdc.coar.type text::journal::journal article
gdc.collaboration.industrial false
gdc.description.department İzmir Institute of Technology en_US
gdc.description.departmenttemp [Meruvu, Haritha] Revathi Hosp, Revathi Diagnost & Labs, Rajahmundry, Andhra Pradesh, India; [Meruvu, Haritha] Izmir Inst Technol, Dept Food Engn, Fac Engn, Izmir, Turkiye; [Meruvu, Haritha] Andhra Univ, Dept Chem Engn, Visakhapatnam, Andhra Pradesh, India en_US
gdc.description.endpage 31271
gdc.description.endpage 31271 en_US
gdc.description.issue 24 en_US
gdc.description.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
gdc.description.scopusquality Q2
gdc.description.startpage 31259
gdc.description.startpage 31259 en_US
gdc.description.volume 14
gdc.description.volume 14 en_US
gdc.description.woscitationindex Science Citation Index Expanded
gdc.description.wosquality Q2
gdc.identifier.openalex W4387093046
gdc.identifier.wos WOS:001163772100007
gdc.index.type WoS
gdc.index.type Scopus
gdc.oaire.diamondjournal false
gdc.oaire.impulse 0.0
gdc.oaire.influence 2.635068E-9
gdc.oaire.isgreen true
gdc.oaire.popularity 2.588463E-9
gdc.oaire.publicfunded false
gdc.oaire.sciencefields 0301 basic medicine
gdc.oaire.sciencefields 0303 health sciences
gdc.oaire.sciencefields 03 medical and health sciences
gdc.openalex.collaboration International
gdc.openalex.fwci 0.0
gdc.openalex.normalizedpercentile 0.16
gdc.opencitations.count 0
gdc.plumx.mendeley 2
gdc.plumx.scopuscites 0
gdc.scopus.citedcount 0
gdc.wos.citedcount 0
relation.isOrgUnitOfPublication.latestForDiscovery 9af2b05f-28ac-4003-8abe-a4dfe192da5e

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Name:
Enhanced-production.pdf
Size:
3.52 MB
Format:
Adobe Portable Document Format